CCK-4

Cholecystokinin-4 (CCK-4)

Chemical structure of CCK-4

Cholecystokinin-4 (CCK-4) is a peptide fragment of the hormone cholecystokinin (CCK), which is involved in various physiological processes in the body. CCK-4 is composed of the first four amino acids of the CCK peptide sequence. It is known for its role in inducing panic attacks when administered to humans, making it a useful tool in the study of anxiety disorders.

Structure and Function

CCK-4 is a tetrapeptide, meaning it consists of four amino acids. The sequence of these amino acids is crucial for its biological activity. CCK-4 mimics the action of the full-length cholecystokinin hormone but with a more specific and potent effect on the central nervous system.

In the body, CCK-4 acts as a neurotransmitter and is involved in the regulation of anxiety and panic. It binds to the cholecystokinin receptors, particularly the CCK-B receptor, which is predominantly found in the brain. This interaction is believed to trigger the physiological and psychological responses associated with panic.

Clinical Significance

CCK-4 is used in research on anxiety disorders.

CCK-4 is primarily used in research settings to study the mechanisms underlying panic and anxiety disorders. By inducing panic attacks in a controlled environment, researchers can observe the effects of potential anxiolytic drugs and therapies. This has provided valuable insights into the treatment of conditions such as panic disorder and generalized anxiety disorder.

The administration of CCK-4 is typically done via intravenous injection, and the resulting panic attack is short-lived, allowing for safe and controlled experimentation.

Mechanism of Action

The mechanism by which CCK-4 induces panic is not fully understood, but it is thought to involve the activation of the CCK-B receptors in the brain. This activation leads to a cascade of events that result in the symptoms of a panic attack, such as increased heart rate, sweating, and feelings of impending doom.

Research has shown that individuals with panic disorder may have an increased sensitivity to CCK-4, suggesting a potential biomarker for susceptibility to anxiety disorders.

Research and Development

Ongoing research is focused on understanding the role of CCK-4 and its receptors in the brain. This includes exploring the genetic and environmental factors that influence CCK-4 sensitivity and the development of new therapeutic agents that can modulate its effects.

Related Pages

• Cholecystokinin
• Panic disorder
• Anxiety disorder
• Neurotransmitter